Your browser doesn't support javascript.
loading
Sensibilidad a IGF-I en niños pequeños para la edad gestacional / IGF-I sensitivity in small for gestational age children
Román R., Rossana; Iñíguez V., Germán; Salazar C., Teresa; Avila A., Alejandra; Barrera P., Alvaro; Fuentes G., Ariel; Mericq G., Verónica; Gunn, Ronald D; Cassorla G., Fernando.
Affiliation
  • Román R., Rossana; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Iñíguez V., Germán; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Salazar C., Teresa; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Avila A., Alejandra; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Barrera P., Alvaro; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Fuentes G., Ariel; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Mericq G., Verónica; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
  • Gunn, Ronald D; Insmed. Glen Allen. Virginia. US
  • Cassorla G., Fernando; Universidad de Chile. Instituto de Investigaciones Materno Infantil. Santiago. CL
Rev. méd. Chile ; 134(1): 21-30, ene. 2006. ilus, tab, graf
Article in Es | LILACS | ID: lil-426114
Responsible library: BR1.1
RESUMO

Background:

The lack of catch up growth (CUG) in small for gestational age (SGA) children may be related to a reduced sensitivity to insulin growth factor 1 (IGF-I).

Aim:

To assess the sensitivity to IGF-I in small for gestational age children, measuring basal and post IGF-I nocturnal profile of growth hormone (GH). Patients and

methods:

We studied 34 prepubertal SGA children aged 4 to 11 years. Twenty three had CUG and 11 did not have CUG. As an IGF-I sensitivity test, nocturnal GH levels were measured every 20 minutes from 2300 h to 0700 h, both under baseline conditions and after the administration of a subcutaneous bolus of 1 mg/kg/body weight of the IGF-I + IGFBP-3 complex (Somatokine®).

Results:

At the time of the study, the Z scores for height among children with and without CUG were -1.55 ± 0.22 and -3.24 ± 0.28, respectively (p <0.0001). There were no statistical differences between CUG + vs CUG- patients in mean basal GH (6.6 ± 0.5 and 5.6 ± 0.6 ng/ml, respectively). After Somatokine® administration, mean GH, and the mean GH area under the curve (AUC) decreased significantly in both groups. However, mean overnight GH AUC decreased in all SGA children with CUG, after Somatokine® administration, whereas 3 out of 11 SGA children without CUG had an increase in their mean GH AUC in response to Somatokine®.

Conclusions:

These findings suggest that pituitary sensitivity to IGF-I may be decreased in some SGA children without CUG.
Subject(s)
Full text: 1 Index: LILACS Main subject: Recombinant Fusion Proteins / Infant, Small for Gestational Age / Insulin-Like Growth Factor I / Growth Hormone Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Male / Newborn / Pregnancy Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2006 Type: Article / Congress and conference / Project document
Full text: 1 Index: LILACS Main subject: Recombinant Fusion Proteins / Infant, Small for Gestational Age / Insulin-Like Growth Factor I / Growth Hormone Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Male / Newborn / Pregnancy Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2006 Type: Article / Congress and conference / Project document